Summit Securities Group’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-28
| Closed | -$11K | – | 428 |
|
|
2023
Q2 | $11K | Sell |
28
-15
| -35% | -$5.89K | ﹤0.01% | 628 |
|
|
2023
Q1 | $21K | Buy |
43
+21
| +95% | +$10.3K | ﹤0.01% | 486 |
|
|
2022
Q4 | $9K | Buy |
+22
| New | +$9K | ﹤0.01% | 809 |
|
|
2022
Q3 | – | Sell |
-45
| Closed | -$22K | – | 718 |
|
|
2022
Q2 | $22K | Buy |
45
+36
| +400% | +$17.6K | ﹤0.01% | 557 |
|
|
2022
Q1 | $5K | Buy |
+9
| New | +$5K | ﹤0.01% | 717 |
|